Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33K Buy
+7
New +$1.04K ﹤0.01% 833
2025
Q4
Sell
-324
Closed -$31.6K 928
2025
Q3
$31.6K Buy
+324
New +$26.1K 0.02% 326
2025
Q1
Sell
-365
Closed -$25.5K 137
2024
Q4
$25.5K Buy
365
+50
+16% +$4.15K 0.02% 339
2024
Q3
$25.1K Buy
+315
New +$36.8K 0.02% 350
2024
Q1
Sell
-35
Closed -$4.54K 888
2023
Q4
$4.54K Buy
+35
New +$4.82K ﹤0.01% 573

Other funds holding ACLS

Caitlin John's ACLS Position: Q2 2026 in Review

Caitlin John opened a new position in Axcelis (ACLS) in Q2 2026: 7 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings. This is a return to the name: Caitlin John previously reported a position in ACLS as recently as Q3 2025.

Caitlin John first reported a position in ACLS in Q4 2023 and has held it in 5 quarters since. The position peaked at $31.6K in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Caitlin John held 7 shares of Axcelis worth $1.33K as of Q2 2026.
  • Axcelis was a new Caitlin John position in Q2 2026.
  • Axcelis made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #833 holding.
  • Caitlin John first reported a position in Axcelis in Q4 2023 and has held it in 5 quarters since.
  • Caitlin John's Axcelis position peaked at $31.6K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.